The ability of triterpenes is evidence to inhibit the inflammation in the tumor micron-environment associated with greater reduction of Cox-2 and Twist1 proteins more inhibition of activation of IGF-1R, Stat3, and Src (Cho et al., 2015). The gene discussed is SRC; the disease is neoplasm.